SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin recalling 16,272 bottles of Gatifloxacin Ophthalmic Solution in US market

08 Nov 2021 Evaluate

Lupin is recalling 16,272 bottles of Gatifloxacin Ophthalmic Solution, an antibiotic used to treat bacterial infections of the eyes, in US market. As per the US Food and Drug Administration (USFDA), the company's US-based unit is recalling the affected lot due to failed stability specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

The affected lot has been manufactured at Lupin's Pithampur-based plant in Madhya Pradesh. The lot has been distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc, the report stated. The drug maker initiated the nationwide (US and Puerto Rico) Class III voluntary recall on November 2 this year. As per USFDA, a Class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. The US generic drug market was estimated to be around $115.2 billion in 2019. It is the largest market for pharmaceutical products.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2280.95 -96.95 (-4.08%)
11-May-2026 14:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.75
Dr. Reddys Lab 1289.80
Cipla 1308.60
Zydus Lifesciences 954.90
Lupin 2280.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×